150 related articles for article (PubMed ID: 31412009)
1. Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review.
Surov A; Meyer HJ; Wienke A
Eur Urol Oncol; 2020 Aug; 3(4):489-497. PubMed ID: 31412009
[TBL] [Abstract][Full Text] [Related]
2. Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient - a systematic review and meta analysis.
Meyer HJ; Wienke A; Surov A
BMC Cancer; 2020 May; 20(1):482. PubMed ID: 32460795
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
Woo S; Kim SY; Cho JY; Kim SH
AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
[TBL] [Abstract][Full Text] [Related]
4. Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer.
Wu X; Reinikainen P; Vanhanen A; Kapanen M; Vierikko T; Ryymin P; Hyödynmaa S; Kellokumpu-Lehtinen PL
Diagn Interv Imaging; 2017 Jan; 98(1):63-71. PubMed ID: 27687831
[TBL] [Abstract][Full Text] [Related]
5. [Discussion of correlation between histogram analysis of quantitative diffusion weighted imaging and Gleason score of prostate cancer].
Wen R; Zhao WL; Wei CG; Gu YF; Li MJ; Zhang YY; Shen JK
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):823-828. PubMed ID: 30893724
[No Abstract] [Full Text] [Related]
6. Prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology.
Shan Y; Chen X; Liu K; Zeng M; Zhou J
Abdom Radiol (NY); 2019 Oct; 44(10):3441-3452. PubMed ID: 31144091
[TBL] [Abstract][Full Text] [Related]
7. Dose painting of prostate cancer based on Gleason score correlations with apparent diffusion coefficients.
Grönlund E; Johansson S; Nyholm T; Thellenberg C; Ahnesjö A
Acta Oncol; 2018 May; 57(5):574-581. PubMed ID: 29260950
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
9. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
[TBL] [Abstract][Full Text] [Related]
10. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MRI,
Kitajima K; Yamamoto S; Kawanaka Y; Nakanishi Y; Yamada Y; Go S; Kanematsu A; Kaida H; Yamakado K
Hell J Nucl Med; 2020; 23(1):34-39. PubMed ID: 32222730
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI.
Barbieri S; Brönnimann M; Boxler S; Vermathen P; Thoeny HC
Eur Radiol; 2017 Apr; 27(4):1547-1555. PubMed ID: 27300199
[TBL] [Abstract][Full Text] [Related]
13. Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations.
Helfrich O; Puech P; Betrouni N; Pinçon C; Ouzzane A; Rizk J; Marcq G; Randazzo M; Durand M; Lakroum S; Leroy X; Villers A
J Magn Reson Imaging; 2017 Dec; 46(6):1786-1796. PubMed ID: 28383776
[TBL] [Abstract][Full Text] [Related]
14. Exponential apparent diffusion coefficient in evaluating prostate cancer at 3 T: preliminary experience.
Park SY; Kim CK; Park JJ; Park BK
Br J Radiol; 2016; 89(1058):20150470. PubMed ID: 26653866
[TBL] [Abstract][Full Text] [Related]
15. Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.
Warndahl BA; Borisch EA; Kawashima A; Riederer SJ; Froemming AT
Magn Reson Imaging; 2018 Apr; 47():67-76. PubMed ID: 29103977
[TBL] [Abstract][Full Text] [Related]
16. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology.
Boesen L; Chabanova E; Løgager V; Balslev I; Thomsen HS
J Magn Reson Imaging; 2015 Aug; 42(2):446-53. PubMed ID: 25408104
[TBL] [Abstract][Full Text] [Related]
17. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
[TBL] [Abstract][Full Text] [Related]
18. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
20. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]